Viewing Study NCT02029950


Ignite Creation Date: 2025-12-24 @ 4:55 PM
Ignite Modification Date: 2026-01-04 @ 6:02 PM
Study NCT ID: NCT02029950
Status: COMPLETED
Last Update Posted: 2020-10-14
First Post: 2014-01-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-12-16
Start Date Type: ACTUAL
Primary Completion Date: 2020-05-13
Primary Completion Date Type: ACTUAL
Completion Date: 2020-05-13
Completion Date Type: ACTUAL
First Submit Date: 2014-01-06
First Submit QC Date: None
Study First Post Date: 2014-01-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-10-10
Last Update Post Date: 2020-10-14
Last Update Post Date Type: ACTUAL